Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Norgine
Entity

Norgine

Tracked across 4 events · 25 articles · First seen Apr 07, 2026 · Last active May 28, 2026

Sentiment
25
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (4)
2 70
Business
Norgine PEDMARQSI TGA Australia Approval
Norgine announced that its drug PEDMARQSI (sodium thiosulfate anhydrous) has been registered by the Australia — Therapeutic Goods Administration in Australia. This registration allows for the prevention of ototoxicity (hearing loss) induced by cisplatin chemotherapy…
Impact: Norgine received TGA registration for PEDMARQSI in Australia, expanding its market reach for this specialized medicine.
May 05, 2026 · 6 articles
2 0
Business
Fennec Pharmaceuticals Q1 2026 Earnings
Fennec Pharmaceuticals announced it will release its first quarter 2026 financial results on Thursday, May 14, 2026, before the opening of U.S. financial markets. Management will host a conference call and webcast on the same…
Impact: Norgine has an exclusive licensing agreement with Fennec Pharmaceuticals to commercialize PEDMARQSI in Europe, U.K., Australia, and New Zealand.
May 07, 2026 · 6 articles
4 0
Business
Fennec Pharmaceuticals Q1 2026 Earnings
Fennec Pharmaceuticals reported its financial results for the first quarter ended March 31, 2026, showcasing significant growth with total net revenues of $15.1 million, a 73% increase year-over-year. The company highlighted the expanding adoption of…
Impact: Norgine is the exclusive licensing partner for Fennec Pharmaceuticals' product PEDMARQSI in Europe, the UK, Australia, and New Zealand, contributing to the global commercialization of the drug.
May 14, 2026 · 6 articles
4 30
Business
Fennec PEDMARK Study Expansion
Impact: Norgine has an exclusive licensing agreement with Fennec Pharmaceuticals to commercialize PEDMARQSI (PEDMARK) in Europe, U.K., Australia, and New Zealand.
Apr 07, 2026 · 7 articles
Key Actions (4)
100 Australia — Therapeutic Goods Administration registered PEDMARQSI NorgineNorgine PEDMARQSI TGA...
40 European Union — European Medicines Agency granted marketing authorisation NorgineNorgine PEDMARQSI TGA...
30 United Kingdom granted marketing authorisation NorgineNorgine PEDMARQSI TGA...
30 Switzerland — Swissmedic approved PEDMARQSI NorgineNorgine PEDMARQSI TGA...
NEWSDESK
Track Norgine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.